投資評等
最後更新日期：2012/2/12
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2010/4/27 | Deutsche Bank | Hold >> Buy | |
| 2009/12/30 | Kaufman Bros | Hold >> Buy | $20 >> $25 |
| 2009/9/11 | Roth Capital | Hold >> Buy | $17 >> $22 |
| 2009/6/9 | JMP Securities | Mkt Underperform >> Mkt Outperform | |
| 2009/5/18 | Credit Suisse | Neutral Outperform | $9 $14 |
| 2005/5/2 | AmTech Research | Hold->Buy | 41 |
| 2005/3/22 | UBS | Reduce->Buy | |
| 2003/12/4 | Merrill Lynch | Neutral->Buy | 48 |
| 2003/11/20 | Pacific Growth Equities | Equal Weight->Over Weight | |
| 2003/8/22 | Fahnestock | Sell -> Buy | 46 |
| 2003/8/19 | CIBC Wrld Mkts | Sector Perform -> Sector Outperform | |
| 2003/7/8 | Lehman Brothers | Equal-weight -> Overweight | |
| 2003/7/8 | Lehman Brothers | Equal-weight -> Overweight | |
| 2003/7/8 | Lehman Brothers | Equal-weight -> Overweight | |
| 2003/7/1 | Pacific Crest | Buy -> Strong Buy | 40 |
| 2003/6/30 | Gerard Klauer Mattison | Neutral -> Outperform | |
| 2003/2/20 | Merrill Lynch | Neutral -> Buy | |
| 2003/1/27 | UBS Warburg | Reduce -> Neutral | |
| 2002/8/23 | Wachovia Sec | Buy -> Strong Buy | 50 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2011/11/17 | JMP Securities | Mkt Perform >> Mkt Underperform | 12.5 |
| 2009/10/28 | Roth Capital | Buy >> Hold | $22 >> $15 |
| 2009/6/23 | Deutsche Securities | Buy >> Hold | 13 |
| 2009/6/2 | Barclays Capital | Overweight >> Equal Weight | |
| 2009/5/22 | Global Crown Capital | Overweight >> Neutral | $10 >> $11.50 |
| 2007/10/1 | Lehman Brothers | Overweight Equal-weight | |
| 2007/1/12 | Oppenheimer | Buy Neutral | |
| 2006/8/18 | Global Crown Capital | Overweight Neutral | |
| 2005/6/15 | UBS | Buy->Neutral | |
| 2004/11/19 | Wedbush Morgan | Buy->Hold | |
| 2004/10/25 | Harris Nesbitt | Outperform->Neutral | |
| 2004/10/15 | UBS | Buy->Reduce | |
| 2004/10/11 | AmTech Research | Buy->Hold | |
| 2004/4/21 | Prudential | Neutral->Underweight | |
| 2003/11/20 | CE Unterberg Towbin | ST Buy->ST Mkt Perform | |
| 2003/7/17 | CIBC Wrld Mkts | Sector Outperform -> Sector Perform | |
| 2003/7/17 | CIBC Wrld Mkts | Sector Outperform -> Sector Perform | |
| 2003/7/17 | CIBC Wrld Mkts | Sector Outperform -> Sector Perform | |
| 2003/5/30 | Fahnestock | Neutral -> Sell | |
| 2003/4/8 | UBS Warburg | Neutral -> Reduce | |
| 2002/11/6 | Merrill Lynch | Buy -> Neutral | |
| 2002/10/14 | Wachovia Sec | Strong Buy -> Buy | |
| 2002/10/14 | Salomon Smth Brny | In-line -> Underperform | 25 |
| 2002/8/2 | Salomon Smth Brny | Buy -> Outperform | 42 |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2012/2/2 | Canaccord Genuity | Buy | 20 |
| 2011/10/12 | RBC Capital Mkts | Outperform | 21 |
| 2010/10/8 | The Benchmark Company | Buy | |
| 2010/3/17 | Auriga U.S.A | Buy | 25 |
| 2009/11/20 | BMO Capital Markets | Outperform | |
| 2009/10/19 | Citigroup | Buy | 21 |
| 2009/3/24 | Deutsche Securities | Buy | |
| 2006/3/21 | Kaufman Bros | Hold | 60 |
| 2005/11/29 | Morgan Keegan | Mkt Perform | |
| 2005/8/16 | Caris Company | Above Average | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2011/6/8 | Auriga | Buy | 18 |
| 2011/4/5 | Kaufman Bros | Buy | 20 |
| 2010/2/24 | Stifel Nicolaus | Buy | 26 |
| 2003/9/30 | CSFB | Outperform | 50 |
| 2003/8/14 | Merrill Lynch | Neutral | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2012/1/30 | Barclays Capital | Equal Weight | $13 >> $15 |
| 2011/8/19 | Barclays Capital | Equal Weight | $15 >> $13 |
| 2011/5/23 | FBR Capital | Outperform | $23 >> $21 |
| 2011/3/4 | Deutsche Bank | Buy | $25 >> $23 |
| 2011/3/4 | Stifel Nicolaus | Buy | $28 >> $26 |
| 2011/3/4 | FBR Capital | Outperform | $25 >> $23 |
| 2010/12/13 | Barclays Capital | Equal Weight | $20 >> $22 |
| 2010/8/16 | Deutsche Bank | Buy | $28 >> $25 |
| 2010/3/5 | FBR Capital | Outperform | $25 >> $27 |
| 2010/3/2 | Caris & Company | Above Average | $21 >> $24 |